Objective Although vasodilators are used in acute heart failure (AHF) management, there have been no clear supportive evidence regarding their routine use. Recent European guidelines recommend systolic blood pressure (SBP) reduction in the range of 25% during the first few hours after diagnosis. This study aimed to examine clinical and prognostic significance of early treatment with intravenous vasodilators in relation to their subsequent SBP reduction in hospitalised AHF. Methods We performed post hoc analysis of 1670 consecutive patients enrolled in the Registry Focused on Very Early Presentation and Treatment in Emergency Department of Acute Heart Failure. Intravenous vasodilator use within 6 hours of hospital arrival and subsequent SBP ...
BACKGROUND: In hospitalized heart failure patients, a poor diuretic response (DR) during the first d...
BackgroundWorsening heart failure (WHF) symptoms despite initial therapy during admission for acute ...
Prompt treatment may mitigate the adverse effects of congestion in the early phase of heart failure ...
Objective Although vasodilators are used in acute heart failure (AHF) management, there have been no...
Although we have recently witnessed substantial progress in management and outcome of patients with ...
Although we have recently witnessed substantial progress in management and outcome of patients with ...
Aims Changes in systolic blood pressure (SBP) during an admission for acute heart failure (AHF), esp...
BACKGROUND Acute heart failure (AHF) is a life-threatening disease requiring urgent treatment, inclu...
AIMS: Changes in systolic blood pressure (SBP) during an admission for acute heart failure (AHF), es...
OBJECTIVES: This study sought to examine the impact of door-to-diuretic (D2D) time on mortality in p...
International audienceBackground According to new recommendations for the management of acute decomp...
Abstract Aims Optimal pharmacological treatment for chronic heart failure has been established. Howe...
International audienceAgents with vasodilator properties (AVDs) are frequently used in the treatment...
BACKGROUND: In hospitalized heart failure patients, a poor diuretic response (DR) during the first d...
BackgroundWorsening heart failure (WHF) symptoms despite initial therapy during admission for acute ...
Prompt treatment may mitigate the adverse effects of congestion in the early phase of heart failure ...
Objective Although vasodilators are used in acute heart failure (AHF) management, there have been no...
Although we have recently witnessed substantial progress in management and outcome of patients with ...
Although we have recently witnessed substantial progress in management and outcome of patients with ...
Aims Changes in systolic blood pressure (SBP) during an admission for acute heart failure (AHF), esp...
BACKGROUND Acute heart failure (AHF) is a life-threatening disease requiring urgent treatment, inclu...
AIMS: Changes in systolic blood pressure (SBP) during an admission for acute heart failure (AHF), es...
OBJECTIVES: This study sought to examine the impact of door-to-diuretic (D2D) time on mortality in p...
International audienceBackground According to new recommendations for the management of acute decomp...
Abstract Aims Optimal pharmacological treatment for chronic heart failure has been established. Howe...
International audienceAgents with vasodilator properties (AVDs) are frequently used in the treatment...
BACKGROUND: In hospitalized heart failure patients, a poor diuretic response (DR) during the first d...
BackgroundWorsening heart failure (WHF) symptoms despite initial therapy during admission for acute ...
Prompt treatment may mitigate the adverse effects of congestion in the early phase of heart failure ...